OBJECTIVES: This study aimed to estimate the gene loci associated with carcinogenesis of endocervical adenocarcinoma of uterus (EA) and metastasis. Study design Sixteen patients with EA were studied; 6 had nodal metastasis. DNA was extracted from EAs, and subjected to both conventional comparative genomic hybridization (CGH) and array-based CGH. Copy number abnormalities were compared between cases with and without nodal metastasis. RESULTS: In all EAs, high frequencies of copy number losses were detected in genes LRP1B (on 2q21.2), DAB2 (5p13), and DCC (18q21.3), as well as regions 3p, 16q, and 22q, and copy number amplifications in genes NRAS (1p13.2), TOP2A (17q21-q22), NCOA3(AIB1) (20q12), and ARSA (22q tel). Nodal metastasis was associated with high frequencies of copy number loss in genes PGRMC2 and LAMA3 and amplification in CDK6 and NCOA3(AIB1). CONCLUSION: This is the first report of gene copy number alterations spanning the whole genome in EA. These altered genes are speculated to be associated with EAs as a tumor suppressor and/or oncogene.
OBJECTIVES: This study aimed to estimate the gene loci associated with carcinogenesis of endocervical adenocarcinoma of uterus (EA) and metastasis. Study design Sixteen patients with EA were studied; 6 had nodal metastasis. DNA was extracted from EAs, and subjected to both conventional comparative genomic hybridization (CGH) and array-based CGH. Copy number abnormalities were compared between cases with and without nodal metastasis. RESULTS: In all EAs, high frequencies of copy number losses were detected in genes LRP1B (on 2q21.2), DAB2 (5p13), and DCC (18q21.3), as well as regions 3p, 16q, and 22q, and copy number amplifications in genes NRAS (1p13.2), TOP2A (17q21-q22), NCOA3(AIB1) (20q12), and ARSA (22q tel). Nodal metastasis was associated with high frequencies of copy number loss in genes PGRMC2 and LAMA3 and amplification in CDK6 and NCOA3(AIB1). CONCLUSION: This is the first report of gene copy number alterations spanning the whole genome in EA. These altered genes are speculated to be associated with EAs as a tumor suppressor and/or oncogene.
Authors: Renu Shankar; Matthew P Johnson; Nicholas A Williamson; Fiona Cullinane; Anthony W Purcell; Eric K Moses; Shaun P Brennecke Journal: Reprod Sci Date: 2009-12-15 Impact factor: 3.060
Authors: Jane M Knisely; Yonghe Li; Janice M Griffith; Hans J Geuze; Alan L Schwartz; Guojun Bu Journal: Exp Cell Res Date: 2007-06-29 Impact factor: 3.905
Authors: Landon C Brown; Matthew D Tucker; Ramy Sedhom; Eric B Schwartz; Jason Zhu; Chester Kao; Matthew K Labriola; Rajan T Gupta; Daniele Marin; Yuan Wu; Santosh Gupta; Tian Zhang; Michael R Harrison; Daniel J George; Ajjai Alva; Emmanuel S Antonarakis; Andrew J Armstrong Journal: J Immunother Cancer Date: 2021-03 Impact factor: 13.751
Authors: Bo Feng; Tao Tao Dong; Lin Lin Wang; Hou Min Zhou; Hong Chao Zhao; Feng Dong; Min Hua Zheng Journal: PLoS One Date: 2012-08-17 Impact factor: 3.240
Authors: Arno G Beer; Christoph Zenzmaier; Michael Schreinlechner; Jenny Haas; Martin F Dietrich; Joachim Herz; Peter Marschang Journal: Oncotarget Date: 2016-10-18